[{"address1": "401 Professional Drive", "address2": "Suite 260", "city": "Gaithersburg", "state": "MD", "zip": "20879", "country": "United States", "phone": "240 403 4212", "website": "https://www.shuttlepharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter Dale Dritschilo M.B.A., M.D.", "age": 55, "title": "President & COO", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 236000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mira  Jung Ph.D.", "age": 75, "title": "Co-Founder & Chief Scientific Officer for Biology", "yearBorn": 1949, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy J. Lorber CPA", "age": 65, "title": "Chief Financial Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 177511, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tyvin A. Rich M.D.", "age": 75, "title": "Chief Clinical Officer & Chief Medical Officer", "yearBorn": 1949, "fiscalYear": 2024, "totalPay": 218000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael P. Vander Hoek", "age": 64, "title": "Vice President for Operations and Regulatory", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 506634, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher Robert Cooper BBA, M.B.A., MBA", "age": 54, "title": "Interim Chief Executive Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Milton  Brown CSC, M.D., Ph.D.", "age": 59, "title": "Co-Founder", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.6798, "open": 3.6, "dayLow": 3.3328, "dayHigh": 3.6972, "regularMarketPreviousClose": 3.6798, "regularMarketOpen": 3.6, "regularMarketDayLow": 3.3328, "regularMarketDayHigh": 3.6972, "payoutRatio": 0.0, "beta": 0.405, "volume": 29754, "regularMarketVolume": 29754, "averageVolume": 289492, "averageVolume10days": 47160, "averageDailyVolume10Day": 47160, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 1614532, "fiftyTwoWeekLow": 3.0, "fiftyTwoWeekHigh": 82.5, "fiftyDayAverage": 4.0496, "twoHundredDayAverage": 14.2319, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -1870611, "profitMargins": 0.0, "floatShares": 413225, "sharesOutstanding": 461295, "sharesShort": 40689, "sharesShortPriorMonth": 27616, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.088199995, "heldPercentInsiders": 0.05821, "heldPercentInstitutions": 0.0084, "shortRatio": 0.19, "shortPercentOfFloat": 0.0938, "impliedSharesOutstanding": 461295, "bookValue": 12.868, "priceToBook": 0.27199253, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -10466773, "trailingEps": -69.25, "lastSplitFactor": "1:25", "lastSplitDate": 1750032000, "enterpriseToEbitda": 0.202, "52WeekChange": -0.95028406, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 3.5, "recommendationKey": "none", "totalCash": 4512607, "totalCashPerShare": 10.271, "ebitda": -9258005, "totalDebt": 1104194, "quickRatio": 2.532, "currentRatio": 2.783, "debtToEquity": 33.611, "returnOnAssets": -1.15045, "returnOnEquity": -3.46195, "freeCashflow": -4728710, "operatingCashflow": -8615071, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SHPH", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1754086527, "regularMarketTime": 1754078400, "exchange": "NCM", "messageBoardId": "finmb_319499082", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.886136, "regularMarketPrice": 3.5, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1661952600000, "postMarketChangePercent": 1.42857, "postMarketPrice": 3.55, "postMarketChange": 0.05, "regularMarketChange": -0.17980003, "regularMarketDayRange": "3.3328 - 3.6972", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 289492, "fiftyTwoWeekLowChange": 0.5, "fiftyTwoWeekLowChangePercent": 0.16666667, "fiftyTwoWeekRange": "3.0 - 82.5", "fiftyTwoWeekHighChange": -79.0, "fiftyTwoWeekHighChangePercent": -0.95757574, "fiftyTwoWeekChangePercent": -95.028404, "shortName": "Shuttle Pharmaceuticals Holding", "longName": "Shuttle Pharmaceuticals Holdings, Inc.", "marketState": "CLOSED", "epsTrailingTwelveMonths": -69.25, "fiftyDayAverageChange": -0.5496001, "fiftyDayAverageChangePercent": -0.13571714, "twoHundredDayAverageChange": -10.7319, "twoHundredDayAverageChangePercent": -0.7540736, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Shuttle Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]